These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11238142)

  • 1. Wyeth suppresses research on pill, programme claims.
    van Heteren G
    BMJ; 2001 Mar; 322(7286):571. PubMed ID: 11238142
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology on trial--confessions of an expert witness.
    McPherson K
    Lancet; 2002 Sep; 360(9337):889-90. PubMed ID: 12354468
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral contraceptives and venous thromboembolic events.
    Shulman LP; Goldzieher JW; Minkin MJ; Sulak PJ; Thorneycroft I
    J Reprod Med; 2003 Apr; 48(4):306-7. PubMed ID: 12747000
    [No Abstract]   [Full Text] [Related]  

  • 4. [Deep venous thrombosis in an adolescent taking oral contraceptives].
    de Tournemire R; Maugas AC
    Arch Pediatr; 2002 Aug; 9(8):873-4. PubMed ID: 12205799
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hormonal contraception and venous thrombosis].
    Lidegaard Ø
    Ugeskr Laeger; 2013 May; 175(20):1401. PubMed ID: 23663393
    [No Abstract]   [Full Text] [Related]  

  • 6. Pill claimants accuse defendants' witness of "cavalier" attitude.
    Dyer C
    BMJ; 2002 May; 324(7346):1115. PubMed ID: 12003877
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormonal contraception and venous thromboembolic risk in midlife women.
    Lidegaard Ø
    Maturitas; 2013 Jan; 74(1):1-2. PubMed ID: 23098858
    [No Abstract]   [Full Text] [Related]  

  • 8. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP; Deitcher SR
    Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complications of hormonal contraception. 38th Congress of the "Zurich Discussion Group", April 2007].
    Birkhäuser M; Braendle W; Keller PJ; Kiesel L; Kuhl H; Neulen J
    Gynakol Geburtshilfliche Rundsch; 2009; 49(1):39-44. PubMed ID: 19204401
    [No Abstract]   [Full Text] [Related]  

  • 11. Claim launched against makers of third generation pill.
    Dyer C
    BMJ; 2002 Mar; 324(7337):561. PubMed ID: 11884306
    [No Abstract]   [Full Text] [Related]  

  • 12. Diane-35 (cyproterone acetate): safety concerns.
    Wooltorton E
    CMAJ; 2003 Feb; 168(4):455-6. PubMed ID: 12591790
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database.
    Farmer RD; Williams TJ; Simpson EL; Nightingale AL
    BMJ; 2000 Aug 19-26; 321(7259):477-9. PubMed ID: 10948026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombosis--adverse effect of drugs].
    Ota S; Yamada N; Nakano T
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():450-4. PubMed ID: 18074580
    [No Abstract]   [Full Text] [Related]  

  • 15. Wyeth responds to news story on oral contraceptives and DVT.
    Brock P
    BMJ; 2001 Jun; 322(7302):1605. PubMed ID: 11458908
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use.
    Zakharova MY; Meyer RM; Brandy KR; Datta YH; Joseph MS; Schreiner PJ; Rao GH; Divani AA
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):323-31. PubMed ID: 20530058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined hormonal contraception and the risk of venous thromboembolism: a guideline.
    ;
    Fertil Steril; 2017 Jan; 107(1):43-51. PubMed ID: 27793376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.
    Raps M; Helmerhorst FM; Fleischer K; Dahm AE; Rosendaal FR; Rosing J; Reitsma P; Sandset PM; van Vliet HA
    Thromb Haemost; 2013 Apr; 109(4):606-13. PubMed ID: 23407778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives.
    Raps M; Curvers J; Helmerhorst FM; Ballieux BE; Rosing J; Thomassen S; Rosendaal FR; van Vliet HA
    Thromb Res; 2014 Apr; 133(4):640-4. PubMed ID: 24438944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complications of hormonal contraception with estrogen and gestagens in the climacteric and in the postmenopausal period. 39th Congress of the "Zurich Discussion Group", October 2007].
    Birkhäuser M; Braendle W; Kuhl H; Neulen J; Thaler CJ
    Gynakol Geburtshilfliche Rundsch; 2009; 49(1):45-51. PubMed ID: 19204402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.